AngioDynamics, Inc. (ANGO)
12.36
+0.34
(+2.87%)
USD |
NASDAQ |
Oct 23, 16:00
12.37
0.00 (0.00%)
Pre-Market: 20:00
AngioDynamics Gross Profit Margin (Quarterly) : 56.00% for Aug. 31, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2026 | 56.00% |
| May 31, 2026 | 50.87% |
| February 28, 2026 | 49.49% |
| November 30, 2025 | 53.05% |
| August 31, 2025 | 51.78% |
| May 31, 2025 | 49.44% |
| February 28, 2025 | 50.36% |
| November 30, 2024 | 51.26% |
| August 31, 2024 | 50.61% |
| May 31, 2024 | 50.64% |
| February 29, 2024 | 43.33% |
| November 30, 2023 | 46.41% |
| August 31, 2023 | 46.31% |
| May 31, 2023 | 46.06% |
| February 28, 2023 | 44.31% |
| November 30, 2022 | 47.14% |
| August 31, 2022 | 45.95% |
| May 31, 2022 | 47.82% |
| February 28, 2022 | 45.54% |
| November 30, 2021 | 45.56% |
| August 31, 2021 | 45.88% |
| May 31, 2021 | 49.48% |
| February 28, 2021 | 48.10% |
| November 30, 2020 | 48.90% |
| August 31, 2020 | 43.88% |
| Date | Value |
|---|---|
| May 31, 2020 | 43.73% |
| February 29, 2020 | 50.56% |
| November 30, 2019 | 52.87% |
| August 31, 2019 | 52.01% |
| May 31, 2019 | 51.80% |
| February 28, 2019 | 51.13% |
| November 30, 2018 | 51.51% |
| August 31, 2018 | 50.86% |
| May 31, 2018 | 53.03% |
| February 28, 2018 | 49.20% |
| November 30, 2017 | 44.50% |
| August 31, 2017 | 43.48% |
| May 31, 2017 | 44.80% |
| February 28, 2017 | 46.06% |
| November 30, 2016 | 45.74% |
| August 31, 2016 | 46.31% |
| May 31, 2016 | 39.52% |
| February 29, 2016 | 44.42% |
| November 30, 2015 | 45.75% |
| August 31, 2015 | 45.65% |
| May 31, 2015 | 44.28% |
| February 28, 2015 | 42.91% |
| November 30, 2014 | 46.69% |
| August 31, 2014 | 47.27% |
| May 31, 2014 | 45.85% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp. | 66.50% |
| Globus Medical, Inc. | 65.92% |
| Penumbra, Inc. | 66.50% |
| Abbott Laboratories | 57.05% |
| Alphatec Holdings, Inc. | 62.90% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -19.07% |
| Return on Assets | -12.62% |
| Return on Invested Capital | -17.94% |
| Profit Margin (Quarterly) | -8.77% |
| Operating Margin (Quarterly) | -6.33% |
| Return on Net Operating Assets | -16.01% |